Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06197243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults

StatusCompleted
PhaseNot applicable
Started2023-12-14
View on ClinicalTrials.gov ↗

Amendment history

2026-10-01
Results posted: 2026-09-30
2025-12-28
Study Status, Oversight, Document Section v4
Re-verified, no change to tracked fields
2025-05-30
Recruiting→Completed Study Status, Oversight, Study Design, Contacts/Locations v3
Trial statusRecruiting→Completed
Primary completion dateestimated 2024-12-14→confirmed 2025-05-23
Completion dateestimated 2024-12-14→confirmed 2025-05-23
Enrollment targetestimated 30→confirmed 23
Study sitesdetails revised at 1 of 1 site
2024-03-19
Study Status, Outcome Measures v2
Secondary endpoints3 entries, revised
Proportion of participants whom wethe investigators collect primary and secondary outcomes.
2024-02-20
Study Status, Study Description, Arms and Interventions, Outcome Measures v1
Secondary endpoints3 entries, revised
DataProportion Collectionof Analysesparticipants whom we collect primary and secondary outcomes.
Primary endpoints1 entry, revised
BRZA dose reductionchange
Study description-2 characters
[...] cribing augmented with combined acupuncture and yoga. Adults who are 65 years or older that are taking BRZA will be recruited. D [...] eline, 4, 8, and 12 weeks. Throughout the research process, weinvestigators will engage with a Stakeholder Advisory Panel consisting of patients and clinicians.
2023-12-26
Original filing
The main purpose of this 12-week study is to see if a new combination of treatments can help older adults reduce benzodiazepine or related medication use. The treatment combination consists of 1) medical provider visits to gradually reduce the medication dose over 12 weeks, 2) acupuncture treatments, and 3) private yoga classes. Participants will be offered weekly visits for 12 weeks to receive combined treatments. Participants will be provided surveys before, during, and after the study to learn about their experience of the treatments. At the end of the study, participants will be invited to participate in a focus group to learn about their experience in the study.
Trial Details
NCT Number NCT06197243
Lead Sponsor Vanderbilt University Medical Center
Collaborators: National Institute on Aging (NIA)
Conditions Anxiety, Insomnia, Benzodiazepine, Deprescription
Enrollment 23 participants
Start Date 2023-12-14
Primary Completion 2025-05-23 (estimated)
Study Completion 2025-05-23 (estimated)
Updated on ClinicalTrials.gov 2026-09-30